Publication | Closed Access

1,2,4-Oxadiazole derivatives targeting EGFR and c-Met degradation in TKI resistant NSCLC

Medicinal ChemistryC-met DegradationNatural SciencesMedicine1,2,4-Oxadiazole DerivativesTki Resistant NsclcBiomolecular EngineeringPharmacologyPharmaceutical ChemistrySmall MoleculesDrug Discovery